Related Experiment Videos
[Transthoracic lung-biopsy in diffuse lung diseases (author's transl)]
Summary
Percutaneous transthoracic lung biopsies are effective for diagnosing diffuse lung diseases, achieving an 88.3% definitive diagnosis rate. This minimally invasive procedure is cost-effective, with manageable complication rates.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Diagnostic Imaging
Context:
- Diffuse lung diseases present diagnostic challenges.
- Percutaneous transthoracic lung biopsy is an established diagnostic tool.
- Evaluating the efficacy and safety of this procedure in diffuse lung conditions is crucial.
Purpose:
- To report the diagnostic yield and complication rates of percutaneous transthoracic lung biopsies in diffuse lung affections.
- To assess the cost-effectiveness of the procedure.
Summary:
- 360 percutaneous transthoracic lung biopsies were performed for diffuse lung affections.
- A high definitive diagnosis rate of 88.3% was achieved through physician-pathologist collaboration.
- The procedure demonstrated low cost.
- Complications included pneumothoraces (15.8%), lung hemorrhage (5.3%), and one hemothorax.
Impact:
- This study highlights the diagnostic value and cost-effectiveness of percutaneous transthoracic lung biopsy for diffuse lung diseases.
- Findings support its use as a primary diagnostic modality.
- Understanding complication rates aids in patient counseling and management.